Virtual Biopsy of Prostate Cancer Using PSMA PET and AI
Recruiting
Observational Study
Prostate Cancer (Diagnosis)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Male
- Study type
- Observational
- Participants needed
- 220 (estimated)
- Sponsor
- University Hospital of North Norway · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prostate cancer is the most common type of cancer in Norwegian men, but many tumors are slow-growing and do not require treatment. Today, MRI is good at detecting suspicious lesions, yet it cannot reliably distinguish aggressive tumors from low-grade ones. As a result, many men undergo repeated invasive biopsies. New PET tracers targeting PSMA improve tumor localization and may correlate with canc…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* For patients who have undergone biopsies prior to PET:
* Patients referred to clinical PET examination
* For patients who have not had biopsies prior to PET:
* Patients referred to urologist for suspected prostate cancer based on clinical symptoms or elevated PSA-levels
Exclu…
Contacts
No contact information available.